Sangamo Therapeutics Direct Offering: Key Details and Market Impact

Sangamo Therapeutics Direct Offering

Sangamo Therapeutics has initiated a direct offering to raise $24M through a securities purchase agreement. This strategic move involves selling shares and pre-funded warrants to attract investment.

Key Highlights:

• Raise of $24M: The company aims to secure $24M in funding through the offering.
• Shares and Pre-funded Warrants: Sangamo is selling shares and pre-funded warrants to interested investors.

The decision to opt for a direct offering can impact Sangamo's financial standing and market performance in the near future.